In Other News · United States · Business

Teva wins FDA approval for monthly schizophrenia injection Weltruza

Source: CNBC

Summary

Teva has received FDA approval for once monthly injectable schizophrenia drug Weltruza. The announcement sent Teva shares gaining in premarket.

You'll be taken to www.cnbc.com

Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.